Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
- Report date:
- 2021
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 22 July 2010
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Landesamt für Umwelt, Rheinland Pfalz, Germany
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Santalol oil: fermentation products of glucose with santalene synthase modified Rhodobacter sphaeroides, distilled, oxidised
- Cas Number:
- 2576531-09-2
- IUPAC Name:
- Santalol oil: fermentation products of glucose with santalene synthase modified Rhodobacter sphaeroides, distilled, oxidised
1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA/Ca
- Remarks:
- Mouse / CBA/CaOlaHsd / SPF
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo RMS GmbH NL-5961 NM Horst, The Netherlands
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 17.8 g – 20.5 g (pretest); 16.1 g – 20.4 g (main test)
- Housing: single housed
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 45-65
- Photoperiod (hrs dark / hrs light): 12 / 12
Study design: in vivo (LLNA)
- Vehicle:
- other: Ethanol
- Concentration:
- 2.5%, 10% and 25% (w/w)
- No. of animals per dose:
- 5
- Details on study design:
- PRE-SCREEN TESTS:
In order to determine the highest test-substance concentration that does not induce local signs of skin irritation and/or systemic toxicity, a pretest (experimental conduct in accordance with GLP, but without a GLP status) was performed. Two mice were treated with test-substance concentrations of 10% and 50% each on three consecutive days. Clinical signs were recorded after each application as well as on day 5 and animals were assessed for potential signs of local irritation on day 1, 2 and 5. Prior to the first application of the test item (day 0), on day 2 and before sacrifice (day 5), the ear thickness was determined using a micrometer. Furthermore, the ears were punched after sacrifice at the apical area using a biopsy punch (Ø 0.8 cm) and were immediately pooled per animal and weighed. Additionally, the weight of the pooled lymph nodes from both sides was determined for each animal.
- Compound solubility:
A solubility experiment was performed according to the recommendations given by OECD 429. The highest test-substance concentration used in the pretest was a 50% solution in ethanol.
- Irritation:
At the 10% concentration, the animals did not show relevant signs of local irritation as confirmed by determination of the ear weights (compared to historical vehicle values; SI per group = 0.99) and ear thickness measurements. Application of the 50% concentration caused considerably increased ear weight (SI per group = 1.20) just below the border of excessive ear skin irritation in one animal.
- Systemic toxicity:
No signs of systemic toxicity were observed
The lymph node weights were increased in both concentrations (SI per group: 1.70 and 2.34 in 10% and 50% test group respectively).
Based on the results of the pretest, the following dose levels were selected for the main study: 2.5%, 10% and 25% (w/w).
MAIN STUDY
TREATMENT PREPARATION AND ADMINISTRATION:
- Test-substance preparation: The test-substance preparation was produced on a weight per weight (w/w) basis shortly before application. After stirring with a magnetic stirrer, the test substance was dissolved in Ethanol.
- Reason for the vehicle: Ethanol was used as the vehicle because good solubility of the preparation was achieved.
- Form of application: Epicutaneous application is simulating dermal contact with the compound, which can occur under practical use conditions.
- Application volume: 25 μL per ear
- Site of application: Dorsal surface of both ears
- Frequency of application: 3 consecutive applications (day 0 – day 2) to the same application site
INVESTIGATIONS:
- Body weight determination: Individual body weights on day 0 prior to the first application and on day 5 prior to the sacrifice of the animals.
- Signs and symptoms: Obvious signs of systemic toxicity and/or local inflammation at the application sites were noted for each animal.
- Mortality: A check for moribund and dead animals was made twice each workday (beginning and end) and once on Saturdays, Sundays and on public holidays.
- ³H-thymidine injection: On study day five (about 66 to 72 hours after the last application of test substance to the ears), ca. 20 μCi 3H-thymidine* in 250 μL sterile saline were injected into the tail vein of the mice.
- Terminal procedures: The animals were sacrificed on study day 5 about 5 hours after 3H-thymidine injection by cervical dislocation under Isoflurane anesthesia.
- Determination of ear weight: Immediately after the death of each animal, a circular piece of tissue (diameter 0.8 cm) was punched out of the apical part of each ear of all animals. The weight of the pooled punches was determined for each animal. These measurements serve for detecting a potential inflammatory ear swelling.
- Removal and weight determination of the lymph nodes: Immediately after removal of the ear punches, the left and right auricular lymph nodes were dissected. The weight of the pooled lymph nodes from both sides was determined for each animal.
- Preparation of cell suspension and determination of cell count: After weight determination, the pooled lymph nodes of each animal were stored in phosphate-buffered saline (PBS) in an ice water bath until further preparation. A single cell suspension was prepared as soon as possible after dissection by carefully passing the lymph nodes through an iron mesh (mesh size 200 μm) into 8 mL phosphate-buffered physiological saline. For determination of cell counts, an aliquot of each suspension was further diluted with Casy®ton in a ratio 1:500. The cell count was determined using a Casy® Counter.
- Measurement of 3H-thymidine incorporation of the lymph node cells: The remaining cell suspensions were washed twice with PBS and precipitated with 5% trichloro-acetic acid (TCA). Each precipitate was transferred to scintillation fluid and incorporation of 3H-thymidine into the cells was measured in a β-scintillation counter.
- Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Mean values and standard deviations of the measured parameters were calculated per test group from the individual values. The stimulation indices of 3H-thymidine incorporation, cell count, lymph node weight and ear weight measurements were calculated by dividing the mean values per test group and/or single animal values by the mean of the vehicle treated group.
3H-thymidine incorporation, cell count, lymph node weight and ear weight -> WILCOXON - Test.
If applicable, the EC (estimated concentration) leading to the respective SI values were calculated by linear or semi-logarithmical regression between the data points directly below and above the SI if possible or by using the two nearest points below or above the SI.
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks:
- 3H-thymidine incorporation
- Value:
- 1.47
- Test group / Remarks:
- 2.5% in Ethanol
- Parameter:
- SI
- Remarks:
- 3H-thymidine incorporation
- Value:
- 3.52
- Test group / Remarks:
- 10% in Ethanol
- Parameter:
- SI
- Remarks:
- 3H-thymidine incorporation
- Value:
- 6.7
- Test group / Remarks:
- 25% in Ethanol
- Parameter:
- EC3
- Remarks:
- 3H-thymidine incorporation
- Value:
- 8.1
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
Stimulation indices (3H-thymidine incorporation)
2.5% in EtOH: 1.47**
10% in EtOH: 3.52**
25% in EtOH: 6.70**
**p<=0.01
Stimulation indices (Cell count)
2.5% in EtOH: 1.34**
10% in EtOH: 1.95**
25% in EtOH: 2.61**
**p<=0.01
EC3 CALCULATION
The threshold concentration for sensitization induction was >2.5% <10%. The EC 3 (estimated concentration that leads to the SI of 3.0) for 3H-thymidine incorporation and the EC 1.5 (estimated concentration that leads to the SI of 1.5) for cell count was calculated by linear regression from the results of these concentrations to be 8.1% and 4.5%, respectively.
CLINICAL OBSERVATIONS:
No signs of systemic toxicity were noticed in all animals during general observation.
BODY WEIGHTS
The expected body weight gain was generally observed during the study period.
SIGNS OF TOXICITY (including dermal irritation at the site of administration, if any, e.g. increased ear thickness).
No local findings were observed during the observation period.
Stimulation indices (Ear weight)
2.5% in EtOH: 1.00
10% in EtOH: 1.04
25% in EtOH: 1.24**
**p<=0.01
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)